{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:57:37Z","timestamp":1780088257852,"version":"3.54.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101072828"],"award-info":[{"award-number":["101072828"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["722609"],"award-info":[{"award-number":["722609"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["860329"],"award-info":[{"award-number":["860329"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["322900939"],"award-info":[{"award-number":["322900939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["403224013"],"award-info":[{"award-number":["403224013"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009706","name":"Erzincan \u00dcniversitesi","doi-asserted-by":"publisher","award":["860329"],"award-info":[{"award-number":["860329"]}],"id":[{"id":"10.13039\/501100009706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The risk of diabetic kidney disease (DKD) progression is significant despite treatment with renin\u2013angiotensin system (RAS) blocking agents. Current clinical tools cannot predict whether or not patients will respond to treatment with RAS inhibitors (RASi). We aimed to investigate whether proteome analysis could identify urinary peptides as biomarkers that could predict the response to angiotensin-converting enzyme inhibitor and angiotensin-receptor blockers treatment to avoid DKD progression. Furthermore, we investigated the comparability of the estimated glomerular filtration rate (eGFR), calculated using four different GFR equations, for DKD progression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We evaluated urine samples from a discovery cohort of 199 diabetic patients treated with RASi. DKD progression was defined based on eGFR percentage slope results between visits (\u223c1 year) and for the entire period (\u223c3 years) based on the eGFR values of each GFR equation. Urine samples were analysed using capillary electrophoresis\u2013coupled mass spectrometry. Statistical analysis was performed between the uncontrolled (patients who did not respond to RASi treatment) and controlled kidney function groups (patients who responded to the RASi treatment). Peptides were combined in a support vector machine-based model. The area under the receiver operating characteristic curve was used to evaluate the risk prediction models in two independent validation cohorts treated with RASi.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The classification of patients into uncontrolled and controlled kidney function varies depending on the GFR equation used, despite the same sample set. We identified 227 peptides showing nominal significant difference and consistent fold changes between uncontrolled and controlled patients in at least three methods of eGFR calculation. These included fragments of collagens, alpha-1-antitrypsin, antithrombin-III, CD99 antigen and uromodulin. A model based on 189 of 227 peptides (DKDp189) showed a significant prediction of non-response to the treatment\/DKD progression in two independent cohorts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The DKDp189 model demonstrates potential as a predictive tool for guiding treatment with RASi in diabetic patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfad223","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T16:41:18Z","timestamp":1699288878000},"page":"873-883","source":"Crossref","is-referenced-by-count":10,"title":["Urinary peptide analysis to predict the response to blood pressure medication"],"prefix":"10.1093","volume":"39","author":[{"given":"Mayra Alejandra","family":"Jaimes Campos","sequence":"first","affiliation":[{"name":"Mosaiques Diagnostics GmbH , Hannover , Germany"},{"name":"University Hospital RWTH Aachen, Institute for Molecular Cardiovascular Research , Aachen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Mavrogeorgis","sequence":"additional","affiliation":[{"name":"Mosaiques Diagnostics GmbH , Hannover , Germany"},{"name":"University Hospital RWTH Aachen, Institute for Molecular Cardiovascular Research , Aachen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Latosinska","sequence":"additional","affiliation":[{"name":"Mosaiques Diagnostics GmbH , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Eder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck , Innsbruck , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Buchwinkler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck , Innsbruck , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mischak","sequence":"additional","affiliation":[{"name":"Mosaiques Diagnostics GmbH , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Siwy","sequence":"additional","affiliation":[{"name":"Mosaiques Diagnostics GmbH , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Complications Research , Copenhagen , Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Mayer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck , Innsbruck , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-2967","authenticated-orcid":false,"given":"Joachim","family":"Jankowski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck , Innsbruck , Austria"},{"name":"Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht , The Netherlands"},{"name":"Aachen-Maastricht Institute for Cardiorenal Disease (AMICARE), University Hospital RWTH Aachen , Aachen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"2024042523513984800_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"2024042523513984800_bib2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2010","journal-title":"Lancet"},{"key":"2024042523513984800_bib3","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024042523513984800_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJMe2215286","article-title":"Chronic kidney disease\u2014another step forward","volume":"388","author":"August","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042523513984800_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2024042523513984800_bib6","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2337\/dc22-1157","article-title":"Dapagliflozin improves the urinary proteomic kidney-risk classifier CKD273 in type 2 diabetes with albuminuria: a randomized clinical trial","volume":"45","author":"Curovic","year":"2022","journal-title":"Diabetes Care"},{"key":"2024042523513984800_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(20)30026-7","article-title":"Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial","volume":"8","author":"Tofte","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024042523513984800_bib8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ekir.2017.06.004","article-title":"Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker","volume":"2","author":"Pontillo","year":"2017","journal-title":"Kidney Int Rep"},{"key":"2024042523513984800_bib9","first-page":"296","article-title":"Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension","volume":"33","author":"Lindhardt","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2024042523513984800_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ckj\/sfaa016","article-title":"Proteomic characterization of obesity-related nephropathy","volume":"13","author":"Wendt","year":"2020","journal-title":"Clin Kidney J"},{"key":"2024042523513984800_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa307","article-title":"Urine proteomics for prediction of disease progression in patients with IgA nephropathy","volume":"37","author":"Rudnicki","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2024042523513984800_bib12","doi-asserted-by":"crossref","first-page":"e62837","DOI":"10.1371\/journal.pone.0062837","article-title":"CKD273, a new proteomics classifier assessing CKD and its prognosis","volume":"8","author":"Argil\u00e9s","year":"2013","journal-title":"PLoS One"},{"key":"2024042523513984800_bib13","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO)","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2024042523513984800_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41581-019-0191-y","article-title":"Measured and estimated glomerular filtration rate: current status and future directions","volume":"16","author":"Levey","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2024042523513984800_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa2203769","article-title":"Cystatin C\u2013based equation to estimate GFR without the inclusion of race and sex","volume":"388","author":"Pottel","year":"2023","journal-title":"N Engl J Med"},{"key":"2024042523513984800_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2048872614521757","article-title":"Relative performance of three formulas to assess renal function at predicting in-hospital hemorrhagic complications in an acute coronary syndrome population. What does the new CKD-EPI formula provide?","volume":"3","author":"Cabanas-Grand\u00edo","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2024042523513984800_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ahj.2015.01.012","article-title":"The proxy of renal function that most accurately predicts short- and long-term outcome after acute coronary syndrome","volume":"169","author":"Orvin","year":"2015","journal-title":"Am Heart J"},{"key":"2024042523513984800_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-47559-w","article-title":"Comparison of five glomerular filtration rate estimating equations as predictors of acute kidney injury after cardiovascular surgery","volume":"9","author":"Jo","year":"2019","journal-title":"Sci Rep"},{"key":"2024042523513984800_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000487500","article-title":"A prospective cohort study in patients with type 2 diabetes mellitus for validation of biomarkers (PROVALID) - study design and baseline characteristics","volume":"43","author":"Eder","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"2024042523513984800_bib20","first-page":"1866","article-title":"Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study","volume":"32","author":"Lindhardt","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2024042523513984800_bib21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","article-title":"DIRECT Programme Study Group. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial","volume":"372","author":"Sj\u00f8lie","year":"2008","journal-title":"Lancet"},{"key":"2024042523513984800_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2024042523513984800_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/ndt\/gfx263","article-title":"Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients","volume":"33","author":"Markoska","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2024042523513984800_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clinbiochem.2012.09.025","article-title":"Technical aspects and inter-laboratory variability in native peptide profiling: the CE\u2013MS experience","volume":"46","author":"Mischak","year":"2013","journal-title":"Clin Biochem"},{"key":"2024042523513984800_bib25","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/elps.201900091","article-title":"Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: the past, the present, and the future","volume":"40","author":"Latosinska","year":"2019","journal-title":"Electrophoresis"},{"key":"2024042523513984800_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/pr800401m","article-title":"Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease","volume":"8","author":"Jantos-Siwy","year":"2009","journal-title":"J Proteome Res"},{"key":"2024042523513984800_bib27","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/elps.200500827","article-title":"Biomarker discovery by CE-MS enables sequence analysis via MS\/MS with platform-independent separation","volume":"27","author":"Z\u00fcrbig","year":"2006","journal-title":"Electrophoresis"},{"key":"2024042523513984800_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/prca.200780082","article-title":"Discovery and validation of urinary biomarkers for prostate cancer","volume":"2","author":"Theodorescu","year":"2008","journal-title":"Proteomics Clin Appl"},{"key":"2024042523513984800_bib29","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jacc.2011.11.066","article-title":"Estimated glomerular filtration rate and prognosis in heart failure: value of the modification of diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and Cockroft-Gault formulas","volume":"59","author":"Zamora","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2024042523513984800_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1177\/0003319713505899","article-title":"Comparison of Cockcroft-Gault and modification of diet in renal disease formulas as predictors of cardiovascular outcomes in patients with myocardial infarction treated with primary percutaneous coronary intervention","volume":"65","author":"Ekmekci","year":"2014","journal-title":"Angiology"},{"key":"2024042523513984800_bib31","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1053\/j.ajkd.2010.11.007","article-title":"Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP)","volume":"57","author":"Stevens","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2024042523513984800_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijcard.2012.08.025","article-title":"Concordance of CKD stages in estimation by the CKD-EPI equation and estimation by the MDRD equation in the Japanese general population: the Iwate KENCO Study","volume":"165","author":"Ohsawa","year":"2013","journal-title":"Int J Cardiol"},{"key":"2024042523513984800_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3343\/alm.2016.36.6.521","article-title":"Comparing results of five glomerular filtration rate-estimating equations in the Korean general population: MDRD Study, revised Lund-Malm\u00f6, and three CKD-EPI equations","volume":"36","author":"Ji","year":"2016","journal-title":"Ann Lab Med"},{"key":"2024042523513984800_bib34","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1053\/j.ajkd.2016.07.021","article-title":"Non-GFR determinants of low-molecular-weight serum protein filtration markers in CKD","volume":"68","author":"Liu","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2024042523513984800_bib35","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","article-title":"Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease","volume":"9","author":"Good","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"2024042523513984800_bib36","first-page":"2079","article-title":"Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis","volume":"32","author":"Siwy","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2024042523513984800_bib37","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1681\/ASN.2007091025","article-title":"Urinary proteomics in diabetes and CKD","volume":"19","author":"Rossing","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2024042523513984800_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prca.202000027","article-title":"Value of urine peptides in assessing kidney and cardiovascular disease","volume":"15","author":"Latosinska","year":"2021","journal-title":"Proteomics Clin Appl"},{"key":"2024042523513984800_bib39","first-page":"1","article-title":"Collagen-derived peptides in CKD: a link to fibrosis","volume":"14","author":"Mavrogeorgis","year":"2022","journal-title":"Toxins"},{"key":"2024042523513984800_bib40","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.3390\/ijms222212123","article-title":"Urinary protein and peptide markers in chronic kidney disease","volume":"22","author":"Chebotareva","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024042523513984800_bib41","doi-asserted-by":"crossref","first-page":"e96955","DOI":"10.1371\/journal.pone.0096955","article-title":"Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease","volume":"9","author":"Nkuipou-Kenfack","year":"2014","journal-title":"PLoS One"},{"key":"2024042523513984800_bib42","doi-asserted-by":"crossref","first-page":"e98380","DOI":"10.1371\/journal.pone.0098380","article-title":"Rapid renal alpha-1 antitrypsin gene induction in experimental and clinical acute kidney injury","volume":"9","author":"Zager","year":"2014","journal-title":"PLoS One"},{"key":"2024042523513984800_bib43","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jth.12652","article-title":"Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"12","author":"Christiansen","year":"2014","journal-title":"J Thromb Haemost"},{"key":"2024042523513984800_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/CCM.0b013e3182742d2c","article-title":"Antithrombin reduces inflammation and microcirculatory perfusion failure in closed soft-tissue injury and endotoxemia","volume":"41","author":"Gierer","year":"2013","journal-title":"Crit Care Med"},{"key":"2024042523513984800_bib45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1042\/CS20160669","article-title":"SerpinC1\/Antithrombin III in kidney-related diseases","volume":"131","author":"Lu","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"2024042523513984800_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12079-017-0445-z","article-title":"CD99 at the crossroads of physiology and pathology","volume":"12","author":"Pasello","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"2024042523513984800_bib47","doi-asserted-by":"crossref","first-page":"e2100133","DOI":"10.1002\/pmic.202100133","article-title":"CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID-19: a potential link to molecular pathophysiology?","volume":"21","author":"Siwy","year":"2021","journal-title":"Proteomics"},{"key":"2024042523513984800_bib48","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"Chronic kidney disease epidemiology collaboration. New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfad223\/54356348\/gfad223.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/5\/873\/57332540\/gfad223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/5\/873\/57332540\/gfad223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T23:53:11Z","timestamp":1714089191000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/39\/5\/873\/7335297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10,31]]},"published-print":{"date-parts":[[2024,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfad223","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2023,10,31]]}}}